Clinical Drug Investigation · 2017 · 11 citations · 28 references
MedicineOncologyPharmacologyMetastasisMolecular OncologyNeoplasiaCancer Molecular PathologyMalignant NeoplasmsMetastatic Cancer ManagementPancreatic CancerAberrant Dna MethylationDurable Clinical ResponseMetastatic Pancreatic CancerPancreatic Cancer PharmacotherapyPancreatic Metastases
28
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
Thierry Conroy, Françoise Desseigne, Marc Ychou et al. · New England Journal of Medicine · 2011 · 7.8K citations · Full text
Medicine, Oncology, Pharmacology +13
<i>MGMT</i> Gene Silencing and Benefit from Temozolomide in Glioblastoma
Monika E. Hegi, Annie‐Claire Diserens, Thierry Gorlia et al. · New England Journal of Medicine · 2005 · 7.3K citations · Full text
EGF Receptor Is Required for KRAS-Induced Pancreatic Tumorigenesis
Christine Ardito-Abraham, Barbara M. Grüner, Kenneth K. Takeuchi et al. · Cancer Cell · 2012 · 526 citations
Matthew H. Kulke, Jason L. Hornick, Christine Frauenhoffer et al. · Clinical Cancer Research · 2008 · 380 citations · Full text
Medicine, Oncology, Chemotherapy +16